Inhibition of C-Jun N-terminal kinase 1, but not c-Jun N-terminal kinase 2, suppresses apoptosis induced by ischemia/reoxygenation in rat cardiac myocytes

Molecular Pharmacology

Volumn 59, Issue 4, 2001, Pages 867-874

  Hreniuk, David ^a   Garay, Michele ^a   Gaarde, William ^b   Monia, Brett P ^b   Mckay, Robert A ^b   Cioffi, Catherine L ^a  

^a NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH   (United States)

^b ISIS PHARMACEUTICALS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

STRESS ACTIVATED PROTEIN KINASE;

ANIMAL CELL; APOPTOSIS; ARTICLE; ENZYME INHIBITION; HEART MUSCLE CELL; HEART MUSCLE ISCHEMIA; NONHUMAN; PRIORITY JOURNAL; RAT; REOXYGENATION; REPERFUSION INJURY;

EID: 0035065271     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: 10.1124/mol.59.4.867     Document Type: Article

References (38)

1. Second-generation antisense oligonucleotides: Structure-activity relationships and the design of improved signal-transduction inhibitors
2. Reperfusion injury: Experimental evidence and clinical implications
3. Signalling via stress-activated mitogen-activated protein kinases in the cardiovascular system
4. Stimulation of the stress-activated mitogen-activated protein kinase subfamilies in perfused heart. P38/RK mitogen-activated protein kinases and c-Jun N-terminal kinases are activated by ischemia/reperfusion
5. The Jun kinase 2 isoform is preferentially required for epidermal growth factor-induced transformation of human A549 lung carcinoma cells
6. Cardioprotective effect of insulin-like growth factor I in myocardial ischemia followed by reperfusion
7. 2-terminal kinase regulation of the apoptotic response of small cell lung cancer cells to ultraviolet radiation
8. Stress- and cell type-dependent regulation of transfected c-Jun N-terminal kinase and mitogen-activated protein kinase kinase isoforms
9. The role of c-Jun N-terminal kinase (JNK) in apoptosis induced by ultraviolet C and γ radiation. Duration of JNK activation may determine cell death and proliferation
10. Stimulation of "stress-regulated" mitogen-activated protein kinase (stress-activated protein kinases/c-Jun N-terminal kinases and p38-mitogen-activated protein kinases) in perfused rat hearts by oxidative and other stresses
11. Activation of c-Jun N-terminal kinases and p38-mitogen-actiavted protein kinases in human heart failure secondary to ischemic heart disease
12. Growth factors and mitogen-activated protein kinases
13. Inhibition of hypoxia/ reoxygenation-induced apoptosis by an antisense oligonucleotide targeted to JNK1 in human kidney cells
14. Reperfusion injury induces apoptosis in rabbit cardiomyocytes
15. Correlation between sustained c-Jun N-terminal protein kinase activation and apoptosis induced by tumor necrosis factor-α in rat mesangial cells
16. Selective interaction of JNK protein kinase isoforms with transcription factors
17. Transcription factor ATF2 regulation by the JNK signal transduction pathway
18. Rapid activation of neutral sphingomyelinase by hypoxia/reoxygenation of cardiac myocytes
19. Signal transduction by the c-Jun N-terminal kinase (JNK)-from inflammation to development
20. Stimulation of c-Jun kinase and mitogen-activated protein kinase by ischemia and reperfusion in the reperfused rat heart
21. The stress-activated protein kinase subfamily of c-Jun kinases
22. Hypoxia/reoxygenation stimulates Jun kinase activity through redox signaling in cardiac myocytes
23. An inhibitor of p38 mitogen-activated protein kinase protects neonatal cardiac myocytes from ischemia
24. Bcl-2 undergoes phosphorylation by c-Jun N-terminal kinase/stress-activated protein kinases in the presence of the constitutively active GTP-binding protein Racl
25. Activation of Akt during simulated ischemia/reperfusion in cardiac myocytes
26. p493F12 kinase: A novel MAP kinase expressed in a subset of neurons in the human nervous system
27. Antitumor activity of a phosphorothioate antisense oligodeoxynucleotide targeted against C-raf kinase
28. Mitogen-activated protein kinase translocates to the nucleus during ischaemia and is activated during reperfusion
29. Inhibition of c-Jun N-terminal kinase 2 expression suppresses growth and induces apoptosis of human tumor cells in a p53-dependent manner
30. 2-terminal kinase-mediated activation of interleukin-1β converting enzyme/CED-3-like protease during anticancer drug-induced apoptosis
31. "Stress responsive" mitogen-activated protein kinases (c-Jun N-terminal kinases and p38 mitogen-activated protein kinases) in the myocardium
32. Requirement of JNK for stress-induced activation of the cytochrome c-mediated death pathway
33. Post-ischemic apoptotic death of rat neonatal cardiac myocytes
34. Annexin V-affinity assay: A review on an apoptosis detection system based on phosphatidylserine exposure
35. Hypoxia-activated apoptosis of cardiac myocytes requires reoxygenation or a pH shift and is independent of p53
36. Tissue-specific pattern of stress kinase activation in ischemic/reperfused heart and kidney
37. Possible involvement of stress-activated protein kinase signaling pathway and Fas receptor expression in prevention of ischemia/reperfusion-induced cardiomyocyte apoptosis by carvedilol
38. The stress-activated protein kinase pathway mediates cell death following injury induced by cis-platinum, UV irradiation and heat